title: [Clinical correlates of social anxiety disorder comorbidity in schizophrenia].
abstract: OBJECTIVE
  The aim of this study is to investigate the social anxiety disorder comorbidity and clinical features in schizophrenia.
  
  
  METHODS
  102 (23 women and 79 men) outpatients who had been followed in the Psychotic Disorders Unit in Bakırköy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery were diagnosed with schizophrenia according to DSM-IV criteria were included in the study. Schizophrenia and Social anxiety disorder  were assessed by a structured clinical interview for DSM-IV. Patients were evaluated with a questionnaire which included demographics, clinical characteristics, Liebowitz social anxiety scale, Positive and Negative Syndrome Scale (PANSS), Calgary depression scale for schizophrenia (CDSS),The Scale of Unawareness of Mental Disorders (SUMD), Short form-36 health survey questionnaire and state-trait anxiety ınventory.
  
  
  RESULTS
  In remission, 22 patients (21.6%) had co-morbid social anxiety disorder. Patients with social anxiety disorder comorbidity, had higher levels of awareness. Their depression scores were higher and functional impairments were lower. These patients had been treated with typical and atypical antipsychotics and antidepressants.
  
  
  CONCLUSIONS
  Social anxiety disorder comorbidity in schizophrenia adversely affects  the quality of life and is not rare. Future studies should be planned with the assesment of social anxiety disorder treatment as well as schizophrenia treatment.
authors.affiliation: Bakırköy Mental Health, Neurology and Neurosurgery Hospital 9, Psychiatry, Kayseri. oyaguclug@yahoo.com
authors.forename: Oya
authors.initials: O
authors.lastname: Güçlü
authors.forename: Murat
authors.initials: M
authors.lastname: Erkıran
authors.forename: Emine Ebru
authors.initials: EE
authors.lastname: Aksu
authors.forename: Haluk
authors.initials: H
authors.lastname: Aksu
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010698:Phobic Disorders / Q000188:drug therapy / Q000453:epidemiology*; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology*; D055815:Young Adult
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents